CDTX vs GM · rev $1.3M vs P/E 7.5, rev $185.02B
Cidara Therapeutics Inc (CDTX) versus General Motors Company (GM) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported GM revenue for 2025-12-31 was $185.02B. Net income was $2.70B. Revenue was down 1.3% from 2024-12-31 to 2025-12-31. GM currently screens at market cap $51.33B and trailing P/E 7.5.
CDTX currently screens at market cap $6.96B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Not investment advice. Open the CDTX and GM stock pages for the full models.
Not investment advice.